Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.
暂无分享,去创建一个
R. Brooner | M. Kidorf | K. Neufeld | V. King | E. Disney | P. Beilenson
[1] R. Brooner,et al. DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM , 2002, Substance use & misuse.
[2] R. Brooner,et al. Influence of Antisocial Personality Subtypes on Drug Abuse Treatment Response , 2001, The Journal of nervous and mental disease.
[3] S. Strathdee,et al. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. , 2000, Social science & medicine.
[4] R. Brooner,et al. Influence of Psychiatric Comorbidity on HIV Risk Behaviors , 2000, Journal of addictive diseases.
[5] M. Stein,et al. Depression among needle exchange program and methadone maintenance clients. , 2000, Journal of substance abuse treatment.
[6] W. H. Hall,et al. Effective medical treatment of opiate addiction , 1998 .
[7] R. Brooner,et al. Drug abuse treatment success among needle exchange participants. , 1998, Public health reports.
[8] G. Woody,et al. Drug abuse treatment as AIDS prevention. , 1998, Public health reports.
[9] D. Vlahov,et al. The role of needle exchange programs in HIV prevention. , 1998, Public health reports.
[10] R. Heimer. Can syringe exchange serve as a conduit to substance abuse treatment? , 1998, Journal of substance abuse treatment.
[11] R. Brooner,et al. Preliminary evidence of good treatment response in antisocial drug abusers. , 1998, Drug and alcohol dependence.
[12] R Brookmeyer,et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[13] D. Simpson,et al. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). , 1997 .
[14] Julio S. G. Montaner,et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.
[15] S. Dinwiddie,et al. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. , 1996, Drug and alcohol dependence.
[16] Samuel R Friedman,et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes , 1996, The Lancet.
[17] R. Brooner,et al. Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. , 1996, Drug and alcohol dependence.
[18] M. Alter,et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. , 1995, American journal of public health.
[19] A. Alterman,et al. Gender differences in diagnosing antisocial personality disorder in methadone patients. , 1995, The American journal of psychiatry.
[20] A. Alterman,et al. Treatment Response of Antisocial Substance Abusers , 1995, The Journal of nervous and mental disease.
[21] J. Gorman,et al. Psychopathology in male and female intravenous drug users with and without HIV infection. , 1994, The American journal of psychiatry.
[22] J C Perry,et al. Problems and considerations in the valid assessment of personality disorders. , 1992, The American journal of psychiatry.
[23] M Davies,et al. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. , 1992 .
[24] R. Bland. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study , 1992 .
[25] L. Sobell. Drug Abuse Treatment: A National Study of Effectiveness, Robert L. Hubbard. 1990. University of North Carolina Press, Chapel Hill, NC. 260 pages. ISBN: 0-8078-1864. $29.95 , 1991 .
[26] J. Ball,et al. The Effectiveness of Methadone Maintenance Treatment , 1991, Springer New York.
[27] R. Brooner,et al. Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. , 1991, Drug and alcohol dependence.
[28] R. Brooner,et al. Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior. , 1990, Drug and alcohol dependence.
[29] R. Malow,et al. Personality disorders classification and symptoms in cocaine and opioid addicts. , 1989 .
[30] M. Weissman,et al. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. , 1986, Archives of general psychiatry.
[31] G. Woody,et al. Sociopathy and psychotherapy outcome. , 1985, Archives of general psychiatry.
[32] E. Khantzian,et al. DSM-III psychiatric diagnosis of narcotic addicts. Recent findings. , 1985, Archives of general psychiatry.
[33] G. Woody,et al. Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. , 1983, Archives of general psychiatry.
[34] M. Weissman,et al. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. , 1982, Archives of general psychiatry.
[35] M. Weissman,et al. Heterogeneity of psychiatric diagnosis in treated opiate addicts. , 1982, Archives of general psychiatry.
[36] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[37] M. Kidorf,et al. Contingent access to clinic privileges reduces drug abuse in methadone maintenance patients. , 1999 .
[38] K. Silverman,et al. Motivating behavior change among illicit-drug abusers: Research on contingency management interventions. , 1999 .
[39] R. Brooner,et al. Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. , 1998, Journal of consulting and clinical psychology.
[40] R. Brooner,et al. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. , 1997, Archives of general psychiatry.
[41] M. First,et al. Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .
[42] M. First,et al. Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .
[43] R. Kessler,et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.
[44] R. Brooner,et al. Psychiatric distress in antisocial drug abusers: relation to other personality disorders. , 1994, Drug and alcohol dependence.
[45] R. Brooner,et al. Antisocial personality disorder and HIV infection among intravenous drug abusers. , 1993, The American journal of psychiatry.
[46] M. Moffitt,et al. Missed psychiatric appointments: who returns and who stays away. , 1993, The American journal of psychiatry.
[47] Nace Ep,et al. Axis II comorbidity in substance abusers. , 1991 .